Paper41369409
AI-Guided Dual Strategy for Peptide Inhibitor Design Targeting Structural Polymorphs of α-Synuclein Fibrils.
Duan J and 2 others. Cells, 2025. Cited by 0 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. AI-Guided Dual Strategy for Peptide Inhibitor Design Targeting Structural Polymorphs of α-Synuclein Fibrils. Papers, record 41369409. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41369409
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| alpha-Synuclein | Major topic |
| Peptides | Major topic |
| Drug Design | Major topic |
| Amyloid | Major topic |
| Humans | |
| Cryoelectron Microscopy | |
| Amino Acid Sequence |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 AG060149 | NIA NIH HHS | United States | R01AG060149 | PubMed and NIH |
Source NIH RePORTER
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Update of | 41279919 | AI-Guided Dual Strategy for Peptide Inhibitor Design Targeting Structural Polymorphs of α-Synuclein Fibrils. | https://conductscience.org/library/papers/41279919 |
Source PubMed
References48
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32031280 | Update on the association between alpha-synuclein and tau with mitochondrial dysfunction: Implications for Parkinson's disease. | Eur J Neurosci | 2021 | https://conductscience.org/library/papers/32031280 | PubMed |
| 2 | 30473927 | The Contribution of Tau, Amyloid-Beta and Alpha-Synuclein Pathology to Dementia in Lewy Body Disorders. | J Alzheimers Dis Parkinsonism | 2018 | https://conductscience.org/library/papers/30473927 | PubMed |
| 3 | 40215967 | Fibril fuzzy coat is important for α-synuclein pathological transmission activity. | Neuron | 2025 | https://conductscience.org/library/papers/40215967 | PubMed |
| 4 | 39327912 | Inhibitor Development for α-Synuclein Fibril's Disordered Region to Alleviate Parkinson's Disease Pathology. | J Am Chem Soc | 2024 | https://conductscience.org/library/papers/39327912 | PubMed |
| 5 | 37940962 | Peptide-based approaches to directly target alpha-synuclein in Parkinson's disease. | Mol Neurodegener | 2023 | https://conductscience.org/library/papers/37940962 | PubMed |
| 6 | 41067404 | Rising Stars: Molecular Mechanisms and Chemical Interventions of α-Synuclein Amyloid Aggregation in Parkinson's Disease. | J Mol Biol | 2025 | https://conductscience.org/library/papers/41067404 | PubMed |
| 7 | 31295458 | Structural Insights into α-Synuclein Fibril Polymorphism: Effects of Parkinson's Disease-Related C-Terminal Truncations. | J Mol Biol | 2019 | https://conductscience.org/library/papers/31295458 | PubMed |
| 8 | 33548114 | Seeded assembly in vitro does not replicate the structures of α-synuclein filaments from multiple system atrophy. | FEBS Open Bio | 2021 | https://conductscience.org/library/papers/33548114 | PubMed |
| 9 | 34265844 | Highly accurate protein structure prediction with AlphaFold. | Nature | 2021 | https://conductscience.org/library/papers/34265844 | PubMed |
| 10 | 39693572 | Structural commonalities determined by physicochemical principles in the complex polymorphism of the amyloid state of proteins. | Biochem J | 2025 | https://conductscience.org/library/papers/39693572 | PubMed |
| 11 | 31105524 | Spreading of α-Synuclein and Tau: A Systematic Comparison of the Mechanisms Involved. | Front Mol Neurosci | 2019 | https://conductscience.org/library/papers/31105524 | PubMed |
| 12 | 40135351 | Identical Seeding Characteristics and Cryo-EM Filament Structures in FTLD-Synuclein and Typical Multiple System Atrophy. | Neuropathol Appl Neurobiol | 2025 | https://conductscience.org/library/papers/40135351 | PubMed |
| 13 | 40231709 | CPL-Diff: A Diffusion Model for De Novo Design of Functional Peptide Sequences with Fixed Length. | Adv Sci (Weinh) | 2025 | https://conductscience.org/library/papers/40231709 | PubMed |
| 14 | 40339505 | PQK7: A novel peptide inhibitor targeting alpha-synuclein fibrillogenesis in Parkinson's disease. | Neuropeptides | 2025 | https://conductscience.org/library/papers/40339505 | PubMed |
| 15 | 40804173 | Target sequence-conditioned design of peptide binders using masked language modeling. | Nat Biotechnol | 2026 | https://conductscience.org/library/papers/40804173 | PubMed |
| 16 | 40288261 | Structure-based artificial intelligence-aided design of MYC-targeting degradation drugs for cancer therapy. | Biochem Biophys Res Commun | 2025 | https://conductscience.org/library/papers/40288261 | PubMed |
| 17 | 40015644 | Structural basis of a distinct α-synuclein strain that promotes tau inclusion in neurons. | J Biol Chem | 2025 | https://conductscience.org/library/papers/40015644 | PubMed |
| 18 | 33094280 | Differential cross-seeding properties of tau and α-synuclein in mouse models of tauopathy and synucleinopathy. | Brain Commun | 2020 | https://conductscience.org/library/papers/33094280 | PubMed |
| 19 | 29969391 | Cryo-EM structure of alpha-synuclein fibrils. | Elife | 2018 | https://conductscience.org/library/papers/29969391 | PubMed |
| 20 | 38198008 | Distinct tau and alpha-synuclein molecular signatures in Alzheimer's disease with and without Lewy bodies and Parkinson's disease with dementia. | Acta Neuropathol | 2024 | https://conductscience.org/library/papers/38198008 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42972149 | From structure prediction to ligand-target recognition: expanding the reach of AlphaFold in natural product research. | Nat Prod Bioprospect | 2026 | https://conductscience.org/library/papers/42972149 |
Source PubMed
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| SNCA | 6622 | PubTator's text mining | https://conductscience.org/library/genes/6622 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41369409
GET https://conductscience.org/api/papers/v1/41369409/references?page=2